Importantly, the interactions between these binding partners were impaired by mutations in nesprin-2, telethonin, and FHL-2 identified in EDMD with DCM and hypertrophic cardiomyopathy patients. The gene discussed is FHL2; the disease is hypertrophic cardiomyopathy.